Insights into the treatment of inflammatory bowel disease in pregnancy.

作者: Sarah E. Shannahan , Jonathan M. Erlich , Mark A. Peppercorn

DOI: 10.1177/1756284819852231

关键词:

摘要: Patients diagnosed with inflammatory bowel disease (IBD) are most commonly in late adolescence or early adulthood, half of patients being before age 32, thus impacting peak years reproduction and family planning. While controlled IBD has no negative effects on the ability to conceive, there is overall a trend towards voluntary childlessness due patients' concerns for adverse fetal outcomes from underlying medication effects. Active at time conception associated worsening activity during pregnancy carries higher risk poor outcomes. It therefore important maintain remission pregnancy, which often achieved pharmacologic therapy. The goal this paper provide comprehensive review current literature safety data treatment breastfeeding women, men planning have children.

参考文章(121)
Kathrin Danninger, Herwig Pieringer, Antonia Puchner, Rudolf Puchner, Impact of TNF-blocking agents on male sperm characteristics and pregnancy outcomes in fathers exposed to TNF-blocking agents at time of conception. Clinical and Experimental Rheumatology. ,vol. 30, pp. 765- ,(2012)
Amy C. Roberts, Robert D. McClure, Richard I. Weiner, George A. Brooks, Overtraining affects male reproductive status Fertility and Sterility. ,vol. 60, pp. 686- 692 ,(1993) , 10.1016/S0015-0282(16)56223-2
C.M. Berlin, Jr., S.J. Yaffe, Disposition of salicylazosulfapyridine (Azulfidine) and metabolites in human breast milk. Developmental pharmacology and therapeutics. ,vol. 1, pp. 31- 39 ,(1980) , 10.1159/000455519
Adeyinka Abinusawa, Srini Tenjarla, Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels Advances in Therapy. ,vol. 32, pp. 477- 484 ,(2015) , 10.1007/S12325-015-0206-4
Vivian W Huang, Hsiu-Ju Chang, Karen I Kroeker, Karen J Goodman, Kathleen M Hegadoren, Levinus A Dieleman, Richard N Fedorak, Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease Canadian Journal of Gastroenterology & Hepatology. ,vol. 29, pp. 95- 103 ,(2015) , 10.1155/2015/715354
Hildur Skuladottir, Allen J. Wilcox, Chen Ma, Edward J. Lammer, Sonja A. Rasmussen, Martha M. Werler, Gary M. Shaw, Suzan L. Carmichael, Corticosteroid use and risk of orofacial clefts. Birth Defects Research Part A-clinical and Molecular Teratology. ,vol. 100, pp. 499- 506 ,(2014) , 10.1002/BDRA.23248
David G. Johns, Ladd D. Rutherford, Petra C. Leighton, Charles L. Vogel, Secretion of methotrexate into human milk American Journal of Obstetrics and Gynecology. ,vol. 112, pp. 978- 980 ,(1972) , 10.1016/0002-9378(72)90824-1
Moshe Ligumsky, Fanny Karmeli, Pinchas Sharon, Uriel Zor, Fortune Cohen, Daniel Rachmilewitz, Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology. ,vol. 81, pp. 444- 449 ,(1981) , 10.1016/0016-5085(81)90594-1
John WD McDonald, Yongjun Wang, David J Tsoulis, John K MacDonald, Brian G Feagan, Methotrexate for induction of remission in refractory Crohn's disease Cochrane Database of Systematic Reviews. ,vol. 12, ,(2014) , 10.1002/14651858.CD003459.PUB4
Megan E.B. Clowse, Douglas C. Wolf, Frauke Förger, John J. Cush, Amanda Golembesky, Laura Shaughnessy, Dirk De Cuyper, Uma Mahadevan, Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol. The Journal of Rheumatology. ,vol. 42, pp. 2270- 2278 ,(2015) , 10.3899/JRHEUM.140189